Medicine and Dentistry
Disease
100%
Neoplasm
65%
Malignant Neoplasm
64%
Infection
49%
Pediatrics
47%
Transplantation
40%
Pancreas Cancer
33%
Surgery
32%
COVID-19
30%
Overall Survival
30%
Rheumatoid Arthritis
28%
Oncology
27%
Metastatic Carcinoma
27%
Non-Hodgkin Lymphoma
27%
Surgeon
27%
Clinical Trial
26%
Diagnosis
26%
Human Immunodeficiency Virus
25%
Radiation Therapy
23%
Injury
23%
Health Care Cost
22%
Chronic Obstructive Pulmonary Disease
22%
Symptom
21%
Cancer
20%
Systematic Review
19%
Liver Transplantation
18%
Breast Cancer
18%
Biological Marker
18%
Pancreas Adenocarcinoma
17%
Diffuse Large B-Cell Lymphoma
17%
Drug Therapy
17%
Clinician
16%
Cancer Cell
15%
Diabetes
15%
Meta-Analysis
14%
Recurrent Disease
14%
Prevalence
14%
Primary Health Care
14%
Quality of Life
14%
Heart Failure
14%
Odds Ratio
14%
Drug Megadose
13%
T Cell
13%
In Vitro
13%
Hodgkin's Lymphoma
13%
Antibiotics
12%
Biopsy
12%
Adverse Event
12%
Prostate Cancer
11%
Epithelial Cell
11%
Magnetic Resonance Imaging
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Hematopoietic Stem Cell
11%
Hazard Ratio
11%
Quality Improvement
10%
Health Care
10%
Peripheral T-Cell Lymphoma
10%
Tumor Cell
10%
Apoplexy
10%
Lung Cancer
10%
Medicine
10%
Virus Infection
10%
Acute Myeloid Leukemia
10%
Non Small Cell Lung Cancer
10%
Mantle Cell Lymphoma
9%
Stem Cell
9%
Pediatrics Patient
9%
Placebo
9%
Short Bowel Syndrome
9%
Cohort Analysis
9%
Echocardiography
9%
Immunotherapy
9%
Public Health
9%
B Cell
9%
Randomized Controlled Trial
9%
Rheumatology
9%
Cardiovascular System
9%
Myocardial Infarction
9%
Combination Therapy
9%
Adolescent
9%
Cell Transplantation
9%
Colorectal Cancer
9%
Diabetes Mellitus
9%
Computer Assisted Tomography
9%
Cancer Therapy
8%
Allograft
8%
Targeted Therapy
8%
Pathogen
8%
Multiple Myeloma
8%
Emergency Department
8%
Cancer Growth
8%
Prognostic Factor
8%
Carcinogenesis
8%
Patient Care
8%
Immunosuppressive Treatment
8%
Survival Rate
8%
Fibroblast
8%
Cardiovascular Disease
8%
Liver Graft
8%
Gene Expression
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
97%
Malignant Neoplasm
74%
Mouse
64%
Neoplasm
55%
Infection
45%
HIV
44%
Rheumatoid Arthritis
37%
Pancreas Cancer
30%
Clinical Trial
29%
Ethanol
26%
Heart Failure
26%
Chronic Obstructive Lung Disease
25%
Chemotherapy
25%
Inflammation
23%
Pharmacokinetics
20%
Biological Marker
20%
Adverse Event
20%
Receptor
19%
Placebo
19%
Prostate Cancer
18%
Overall Survival
17%
Breast Cancer
16%
Nonhodgkin Lymphoma
16%
Combination Therapy
15%
Pancreas Adenocarcinoma
14%
Carcinogenesis
14%
Nanoparticle
14%
Injury
14%
Cytokine
14%
Mouse Model
14%
Heart Infarction
13%
Symptom
13%
SARS Coronavirus
12%
Cardiovascular Disease
11%
Diabetes Mellitus
11%
Coronavirinae
10%
Prevalence
10%
Randomized Controlled Trial
10%
Lung Cancer
10%
Antiinfective Agent
10%
Infectious Agent
10%
Cancer Growth
10%
Metastasis
10%
Methotrexate
10%
Cohort Study
9%
Antibiotics
9%
Carcinogenicity
9%
microRNA
9%
Vitamin D
9%
Cigarette Smoke
9%
Cytotoxicity
9%
Remission
9%
Tumor Necrosis Factor
9%
Liver Disease
9%
Comorbidity
9%
Epileptic Absence
8%
Antibiotic Agent
8%
Tumor Growth
8%
Epidermal Growth Factor Receptor
8%
Antioxidant
8%
Liver Injury
8%
Small Interfering RNA
8%
Fibrosis
8%
Angiotensin II
8%
Recurrent Disease
8%
Coronary Artery Disease
7%
Carcinogen
7%
Human Immunodeficiency Virus Infection
7%
Prodrug
7%
Disease Activity
7%
Doxorubicin
7%
Reactive Oxygen Metabolite
7%
Colorectal Cancer
7%
Quinone Derivative
7%
Parkinson's Disease
7%
Immunotherapy
7%
Transforming Growth Factor
7%
Cyclophosphamide
6%
Biodistribution
6%
Pharmacotherapy
6%
Randomized Clinical Trial
6%
Side Effect
6%
Malonaldehyde
6%
Human Immunodeficiency Virus 1
6%
Diffuse Large B Cell Lymphoma
6%
Dexamethasone
6%
Calcium Ion
6%
Progression Free Survival
6%
Multiple Myeloma
6%
Alcohol Liver Disease
6%
Staphylococcus Aureus
6%
Virus Infection
6%
Non Insulin Dependent Diabetes Mellitus
6%
Mucin
6%
Rituximab
6%
Fluorocarbon
6%
Benzo(a)pyrene
6%
Chemokine
6%
Colon Cancer
6%
Disease Exacerbation
6%
Keyphrases
Rheumatoid Arthritis
15%
NCCN Guidelines
13%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
Non-Hodgkin Lymphoma
12%
Tumor
12%
Pancreatic Cancer
11%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
11%
Confidence Interval
10%
Lymphoma
9%
Overall Survival
9%
United States
9%
Ethanol
9%
Heart Failure
9%
Oncology
9%
Clinical Trials
9%
Chemotherapy
9%
Liver
8%
Chronic Obstructive Pulmonary Disease
8%
COVID-19
8%
Clinical Practice Guidelines
8%
Diffuse Large B-cell Lymphoma (DLBCL)
7%
Inflammation
7%
In Cancer
7%
Transplantation
7%
AIDS/HIV
7%
T Cells
7%
Alcohol
6%
Risk Factors
6%
Chronic Heart Failure
6%
Pancreatic Ductal Adenocarcinoma
6%
Oxidative Stress
5%
Cell Proliferation
5%
Transforming Growth Factor-β
5%
Peripheral T-cell Lymphoma
5%
Growth Factors
5%
Nebraska
5%
Phosphorylation
5%
Microglia
5%
Radiation Therapy
5%
Hepatocytes
5%
Breast Cancer
5%
Clinical Outcomes
5%
Acute Myeloid Leukemia
5%
Malignancy
5%